You are here

  • Home
  • Archive
  • Volume 21, Issue 1
  • Initiating antiretroviral therapy in HIV-infected patients with >500 CD4 cells/µL provides more benefit than delaying treatment

Article metrics

Article menu
Download PDFPDF
Therapeutics/Prevention
Randomised controlled trial
Initiating antiretroviral therapy in HIV-infected patients with >500 CD4 cells/µL provides more benefit than delaying treatment

 

Online download statistics by month:

Online download statistics by month: December 2015 to April 2022

AbstractFullPdf
Dec 20157357
Jan 2016143411
Feb 201698615
Mar 201646226
Apr 20161501
May 201646119
Jun 20162602
Jul 20161011
Aug 20161222
Sep 201620324
Oct 20163740
Nov 20164763
Dec 20161800
Jan 20171811
Feb 20171511
Mar 20171100
Apr 20172082
May 20172643
Jun 20173402
Jul 20174900
Aug 20176511
Sep 20178720
Oct 20175922
Nov 20174000
Dec 20177000
Jan 20188911
Feb 20183000
Mar 20184051
Apr 20186133
May 20185720
Jun 20187110
Jul 20187921
Aug 20185800
Sep 20187400
Oct 20185220
Nov 20186820
Dec 20184511
Jan 20195301
Feb 20194000
Mar 20195322
Apr 20194422
May 20191000
Jun 20192200
Jul 20192110
Aug 20193221
Sep 20192500
Oct 20191900
Nov 201921000
Dec 20196902
Jan 20201405
Feb 20202711
Mar 20202211
Apr 2020900
May 20203002
Jun 20201810
Jul 20205031
Aug 20201202
Sep 20202100
Oct 20203200
Nov 20202010
Dec 20201910
Jan 20212510
Feb 20212600
Mar 20212911
Apr 20212020
May 20213421
Jun 2021421
Sep 2021330
Oct 20211411
Nov 20211700
Dec 20214100
Jan 20221110
Feb 20222210
Mar 20223600
Apr 20221400
Total2977101154